We are live on ! Find out more
AP

Advisor Partners Portfolio holdings

AUM $1.42B
1-Year Est. Return 3.97%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
-3.97%
3 Year Est. Return
+63.81%
5 Year Est. Return
+114.27%
10 Year Est. Return
AUM
$203M
AUM Growth
+$21M
Cap. Flow
+$11.7M
Cap. Flow %
5.77%
Top 10 Hldgs %
18.46%
Holding
291
New
29
Increased
177
Reduced
71
Closed
10

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.87M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$459K
3
MSFT icon
Microsoft
MSFT
+$397K
4
VZ icon
Verizon
VZ
+$329K
5
T icon
AT&T
T
+$264K

Sector Composition

Rank Sector Weight
1 Healthcare 16.59%
2 Financials 16.12%
3 Technology 14.9%
4 Energy 10.41%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.59T
$8.16M 4.02%
351,192
+88,020
+33% +$1.87M
XOM icon
2
ExxonMobil
XOM
$643B
$4.46M 2.19%
44,247
+1,053
+2% +$106K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.13T
$4.08M 2.01%
140,023
+16,923
+14% +$459K
MSFT icon
4
Microsoft
MSFT
$3.75T
$4M 1.97%
96,014
+9,812
+11% +$397K
JNJ icon
5
Johnson & Johnson
JNJ
$640B
$3.48M 1.71%
33,248
+296
+0.9% +$29.9K
WFC icon
6
Wells Fargo
WFC
$257B
$3.18M 1.57%
60,556
+648
+1% +$32.6K
GE icon
7
GE Aerospace
GE
$356B
$2.62M 1.29%
20,795
+358
+2% +$45.5K
IBM icon
8
IBM
IBM
$225B
$2.52M 1.24%
14,545
+528
+4% +$95K
JPM icon
9
JPMorgan Chase
JPM
$942B
$2.51M 1.24%
43,585
+1,920
+5% +$108K
PFE icon
10
Pfizer
PFE
$160B
$2.5M 1.23%
88,667
-1,915
-2% -$54.6K
MRK icon
11
Merck
MRK
$369B
$2.45M 1.21%
44,462
+1,541
+4% +$84.1K
PG icon
12
Procter & Gamble
PG
$333B
$2.4M 1.18%
30,573
+79
+0.3% +$6.37K
CVX icon
13
Chevron
CVX
$392B
$2.4M 1.18%
18,390
+497
+3% +$61.8K
T icon
14
AT&T
T
$174B
$2.31M 1.14%
86,485
+9,852
+13% +$264K
KO icon
15
Coca-Cola
KO
$383B
$2.16M 1.06%
50,967
+6,446
+14% +$262K
VZ icon
16
Verizon
VZ
$205B
$2.15M 1.06%
43,879
+6,790
+18% +$329K
DIS icon
17
Walt Disney
DIS
$184B
$2.06M 1.02%
24,055
+221
+0.9% +$18.1K
BAC icon
18
Bank of America
BAC
$428B
$2.03M 1%
132,284
+2,327
+2% +$36.1K
INTC icon
19
Intel
INTC
$487B
$2.03M 1%
65,733
+3,387
+5% +$92.8K
GILD icon
20
Gilead Sciences
GILD
$185B
$1.92M 0.95%
23,161
+1,259
+6% +$98K
C icon
21
Citigroup
C
$223B
$1.9M 0.94%
40,432
+675
+2% +$32.1K
ORCL icon
22
Oracle
ORCL
$438B
$1.89M 0.93%
46,721
+3,918
+9% +$161K
COP icon
23
ConocoPhillips
COP
$156B
$1.86M 0.92%
21,699
-281
-1% -$21.9K
CVS icon
24
CVS Health
CVS
$119B
$1.82M 0.9%
24,182
+1,276
+6% +$96.4K
PEP icon
25
PepsiCo
PEP
$191B
$1.81M 0.89%
20,210
+1,717
+9% +$148K

Similar funds

Advisor Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Advisor Partners held 291 positions worth $203M, up 12% from $182M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Advisor Partners deployed $11.7M of net new capital in Q2 2014, opening 29 new positions and adding to 177 existing holdings. Its largest new stake was Exelon: 9,674 shares worth $252K.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Norfolk Southern, an estimated $84.8K trimmed.

  • Advisor Partners's largest Q2 2014 buy was Exelon: 9,674 shares worth $252K.
  • Advisor Partners added most to Apple in Q2 2014, an estimated $1.87M increase.
  • Advisor Partners's biggest Q2 2014 reduction was Norfolk Southern, cutting an estimated $84.8K.
  • Advisor Partners fully exited Marathon Petroleum in Q2 2014, selling an estimated $656K.
  • Advisor Partners's ten largest holdings make up 18% of its $203M portfolio in Q2 2014.
  • Advisor Partners opened 29 new positions and closed 10 in Q2 2014.
  • Advisor Partners's portfolio value rose 12% quarter-over-quarter to $203M.

Based on Advisor Partners's 13F filing for Q2 2014, filed 31 Jul 2014.